This episode delves into allegations against Teladoc Health's BetterHelp platform, a service that connects patients with licensed mental health therapists. The investigation reveals a concerning trend: patients unknowingly receiving "therapy" from AI chatbots like ChatGPT, despite paying for human therapists.

The Deception: Patients are charged up to $400 per month for therapy sessions via live chat, video, or telephone, with the promise of 24/7 access to a licensed therapist. However, some therapists are allegedly using AI to generate responses, raising ethical questions and potentially harming vulnerable individuals.
Whistleblower Accounts: The episode features firsthand accounts from patients who confronted their therapists and received confessions of AI use, supported by corroborating evidence like screenshots. AI detection programs have also confirmed that some therapist messages were AI-generated.
Perverse Incentives: BetterHelp's compensation structure is scrutinized, revealing that therapists receive bonuses tied to the quantity of words they type, incentivizing them to use AI for generating long, generic responses. Therapists are also pushed to overload their schedules and respond to 24/7 patient messages, increasing the temptation to cut corners with AI.
Company Awareness: Despite BetterHelp's official policy against AI use and warnings about its potential harm, the company appears to turn a blind eye to the issue.
Financial Implications: The episode explores how patient dissatisfaction with AI therapy could lead to falling profits and declining user growth for BetterHelp, which accounts for a significant portion of Teladoc's revenue.
Accounting Issues: Beyond BetterHelp, the episode investigates Teladoc's accounting practices, alleging that the company is shifting R&D expenses to inflate profitability and cash flow.
Insider Activity: The episode touches on executive departures and insider selling, suggesting a lack of confidence in Teladoc's future.

The episode questions the true nature of care provided by BetterHelp and the potential ramifications for patients and investors alike.

Source: Blue Orca is Short Teladoc Health, Inc.